Axsome Therapeutics, Inc. · NASDAQ:AXSM
Coleman Mark sold 17,537 Axsome Therapeutics, Inc. shares (Form 4)
Traded May 29 to Jun 2, 2026 · Filed Jun 2, 2026
From May 29 to Jun 2, 2026, Coleman Mark (Director) sold 17,537 Axsome Therapeutics, Inc. shares at an average US$229.20 for US$4.02M under a trading plan, leaving 29,603 shares. Filed Jun 2, 2026 (Form 4).
- Sold
- 17,537 shares
- Price
- US$229.20 average (US$223.39 to US$233.46)
- Value
- US$4.02M
- Holding after
- 29,603 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Common Stock | Sale | 6,000 | US$233.46 | 41,140 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 6,000 | US$230.30 | 35,140 | Direct |
| Jun 2, 2026 | Common Stock | Sale | 5,537 | US$223.39 | 29,603 | Direct |
Source
Related
- Axsome Therapeutics, Inc.
- Coleman Mark
- Axsome Therapeutics, Inc. shareholders
- Form 4 · Coleman Mark · Jun 10, 2026
- Form 4 · Jacobson Mark L. · Sep 3, 2026
- Form 4 · Tabuteau Herriot · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Tabuteau Herriot · Jul 1, 2026
- Form 4 · Jeffs Roger · Jun 11, 2026